Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Immediate vs Delayed Zoledronic Acid in Early Breast Cancer
NCT05164952Phase 3Unknown
- Sponsor
- Assiut University
- Start
- Sep 2021
- Primary completion
- Aug 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of zoledronic acid in breast cancer, sponsored by Assiut University. Status: unknown.
02
Drugs
zoledronic acid
03
Conditions
breast cancer
Beyond the preview
Go deeper on NCT05164952.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05164952.